{
    "2019-04-24": [
        [
            {
                "time": "2019-04-25",
                "original_text": "Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q1 Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q1 Earnings",
                        "Beat Estimates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "Pre-Market Earnings Report for April 25, 2019 : CMCSA, MMM, ABBV, MO, UPS, BMY, RTN, ITW, MMC, WM, AEP, BAX",
                "features": {
                    "keywords": [
                        "Pre-Market",
                        "Earnings Report",
                        "CMCSA",
                        "ABBV",
                        "BMY"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "AbbVie Expected to Earn $2.06 a share",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Expected",
                        "Earn"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "5 Turnaround Earnings Charts You Must See",
                "features": {
                    "keywords": [
                        "Turnaround",
                        "Earnings",
                        "Charts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "Why Earnings Season Could Be Great for AbbVie (ABBV)",
                "features": {
                    "keywords": [
                        "Earnings Season",
                        "Great",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Q1 Earnings",
                        "Spinraza",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Hereâ€™s what to expect",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bristol-Myers Squibb",
                        "First-Quarter",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova",
                "features": {
                    "keywords": [
                        "FDA",
                        "Greenlights",
                        "AbbVie",
                        "Psoriasis Drug",
                        "Novartis",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}